{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:43:28Z","timestamp":1792205008029,"version":"4.4.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"abstract":"<jats:p>Gabapentin (GAB), an anticonvulsant, is commonly used in veterinary medicine to manage anxiety, pain, and epilepsy. Although it is widely used, achieving personalized dosing for small animals remains a significant challenge. Three-dimensional printing (3DP), particularly semi-solid extrusion (SSE), has shown promise in producing individualized dosage forms efficiently and with precision. Despite its advantages, SSE is limited by the need to freshly prepare the ink for printing and the extended post-processing times required for curing or solidifying the printed objects. This study investigated for the first time the feasibility of reusing a formulation designed for veterinary patients. The chewable tablets in this study were made using an already available proprietary gelatin-based excipient base, CuraVet\u00ae. Two formulations with varying GAB concentrations were printed using the same syringe initially and then again after 14\u202fdays of refrigerated storage. The formulation that contained a lower concentration of GAB maintained printability and dosing precision without requiring adjustments to printer settings, enabling the production of chewable tablets in under 30\u202fmin with a minimal amount of active work required. In contrast, the higher concentration formulation exhibited crystal formation, indicating instability. This proof-of-concept study demonstrated the feasibility of using reusable gelatin-based inks for on-demand 3D printing of veterinary medicines, highlighting their potential for clinical adoption in veterinary practices and pharmacies, provided that stability is carefully characterized.<\/jats:p>","DOI":"10.3389\/fvets.2026.1835903","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:37:54Z","timestamp":1778647074000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Reusable gelatin-based inks for 3D printing of veterinary gabapentin tablets: a sustainable approach"],"prefix":"10.3389","volume":"13","author":[{"given":"Alex","family":"Taylor","sequence":"first","affiliation":[{"name":"School of Pharmacy, University of Eastern Finland","place":["Kuopio, Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarkko","family":"Ketolainen","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of Eastern Finland","place":["Kuopio, Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattias","family":"Paulsson","sequence":"additional","affiliation":[{"name":"Department of Women\u2019s and Children\u2019s Health, Uppsala University","place":["Uppsala, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Autenrieth","sequence":"additional","affiliation":[{"name":"Division of Molecular Pharmaceutics, Department of Pharmacy, Uppsala Biomedical Center, Uppsala University","place":["Uppsala, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Lindh","sequence":"additional","affiliation":[{"name":"Division of Nanotechnology and Functional Materials, Department of Materials Science and Engineering, Uppsala University","place":["Uppsala, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"R\u00f6nnberg","sequence":"additional","affiliation":[{"name":"Department of Animal Biosciences, Swedish University of Agricultural Sciences","place":["Uppsala, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.3390\/ani13122045","article-title":"Gabapentin: clinical use and pharmacokinetics in dogs, cats, and horses","volume":"13","author":"Di Cesare","year":"2023","journal-title":"Animals"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"103841","DOI":"10.1016\/j.jddst.2022.103841","article-title":"Palatability assessment of oral dosage forms for companion animals: a systematic review","volume":"77","author":"Adenot","year":"2022","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"471","DOI":"10.5455\/ovj.2021.v11.i3.21","article-title":"Dosage variability of veterinary drug products, containing furosemide, linked to tablet splitting","volume":"11","author":"Maggi","year":"2021","journal-title":"Open Vet J"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"120118","DOI":"10.1016\/j.ijpharm.2020.120118","article-title":"3D printing of gummy drug formulations composed of gelatin and an HPMC-based hydrogel for pediatric use","volume":"594","author":"Tagami","year":"2021","journal-title":"Int J Pharm"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"125099","DOI":"10.1016\/j.ijpharm.2024.125099","article-title":"Development of axitinib-loaded polymeric ocular implants for the treatment of posterior ocular diseases","volume":"669","author":"Annuryanti","year":"2025","journal-title":"Int J Pharm"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.3390\/pharmaceutics14071339","article-title":"Compounding tailored veterinary chewable tablets close to the point-of-care by means of 3D printing","volume":"14","author":"Sj\u00f6holm","year":"2022","journal-title":"Pharmaceutics."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1080\/17425247.2024.2399706","article-title":"3D printed personalized therapies for pediatric patients affected by adrenal insufficiency","volume":"21","author":"Rodr\u00edguez-Pombo","year":"2024","journal-title":"Expert Opin Drug Deliv"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s12247-024-09904-z","article-title":"3D drug printing by semi-solid extrusion through reusable cartridges: usability evaluation","volume":"20","author":"Rege","year":"2025","journal-title":"J Pharm Innov"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.3390\/pharmaceutics15041218","article-title":"3D printing technology based on versatile gelatin-carrageenan gel system for drug formulations","volume":"15","author":"Liang","year":"2023","journal-title":"Pharmaceutics"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.3390\/pharmaceutics15061642","article-title":"Characterization and validation of a new 3D printing ink for reducing therapeutic gap in pediatrics through individualized medicines","volume":"15","author":"D\u00edaz-Torres","year":"2023","journal-title":"Pharmaceutics"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.jcis.2023.07.055","article-title":"Synergistic stabilization of emulsion gel by nanoparticles and surfactant enables 3D printing of lipid-rich solid oral dosage forms","volume":"650","author":"Johannesson","year":"2023","journal-title":"J Colloid Interface Sci"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.3390\/pharmaceutics16121532","article-title":"The formulation and evaluation of customized prednisolone gel tablets prepared by an automated extrusion-based material deposition method","volume":"16","author":"Tihhonova","year":"2024","journal-title":"Pharmaceutics"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"106190","DOI":"10.1016\/j.ejps.2022.106190","article-title":"Semi-solid extrusion 3D printing of tailored ChewTs for veterinary use - a focus on spectrophotometric quantification of gabapentin","volume":"174","author":"Sj\u00f6holm","year":"2022","journal-title":"Eur J Pharm Sci"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1016\/j.jpba.2006.12.020","article-title":"Development and application of a validated HPLC method for the determination of gabapentin and its major degradation impurity in drug products","volume":"43","author":"Ciavarella","year":"2007","journal-title":"J Pharm Biomed Anal"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1208\/s12249-011-9652-8","article-title":"The stabilizing effect of moisture on the solid-state degradation of gabapentin","volume":"12","author":"Zong","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"661","DOI":"10.2165\/11536200-000000000-00000","article-title":"A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin","volume":"49","author":"Bockbrader","year":"2010","journal-title":"Clin Pharmacokinet"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.japh.2019.02.012","article-title":"Compounded gabapentin for neuropathic pain: stability and beyond-use date (BUD) in some commonly used bases","volume":"59","author":"Shakshuki","year":"2019","journal-title":"J Am Pharm Assoc"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1016\/j.xphs.2020.07.033","article-title":"Impact of surfactants on the functionality of prefilled syringes","volume":"109","author":"Wang","year":"2020","journal-title":"J Pharm Sci"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"114418","DOI":"10.1016\/j.ejpb.2024.114418","article-title":"The silicone depletion in combination products induced by biologics","volume":"203","author":"Moll","year":"2024","journal-title":"Eur J Pharm Biopharm"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1016\/j.xphs.2024.05.032","article-title":"Lessons to learn for 3D printing of drug products by semisolid extrusion (SSE)","volume":"113","author":"Sun","year":"2024","journal-title":"J Pharm Sci"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jconrel.2021.02.027","article-title":"Semi-solid extrusion 3D printing in drug delivery and biomedicine: personalised solutions for healthcare challenges","volume":"332","author":"Seoane-Via\u00f1o","year":"2021","journal-title":"J Control Release"},{"key":"ref22","volume-title":"Chapter 2.9.5. Uniformity of Mass of Single-Dose Preparations","year":"2024"},{"key":"ref23","volume-title":"Chapter 2.9.6. Uniformity of Content of Single-Dose Preparations","year":"2024"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"e0175208","DOI":"10.1371\/journal.pone.0175208","article-title":"Stability of gabapentin in extemporaneously compounded oral suspensions","volume":"12","author":"Friciu","year":"2017","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"123413","DOI":"10.1016\/j.ijpharm.2023.123413","article-title":"Quality attributes for printable emulsion gels and 3D-printed tablets: towards production of personalized dosage forms","volume":"646","author":"Johannesson","year":"2023","journal-title":"Int J Pharm"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"105786","DOI":"10.1016\/j.jddst.2024.105786","article-title":"Surface modified PLGA nanoparticles of gabapentin: biodistribution and pharmacodynamic investigation via intranasal route","volume":"97","author":"Rai","year":"2024","journal-title":"J Drug Deliv Sci Technol."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"105266","DOI":"10.1016\/j.ejps.2020.105266","article-title":"Investigation of semi-solid formulations for 3D printing of drugs after prolonged storage to mimic real-life applications","volume":"146","author":"Aita","year":"2020","journal-title":"Eur J Pharm Sci"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1007\/s10973-013-3166-4","article-title":"Thermal transitions of gelatin evaluated using DSC sample pans of various seal integrities","volume":"114","author":"Mukherjee","year":"2013","journal-title":"J Therm Anal Calorim"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1134\/S0018143920040141","article-title":"A DSC study of the endothermic process, associated with hydrogen bonding, in polysaccharides after high-pressure plastic deformation","volume":"54","author":"Zhorin","year":"2020","journal-title":"High Energy Chem"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"7234","DOI":"10.1021\/acs.cgd.2c00904","article-title":"Multivariate analysis of a highly effective drug combination tablet containing the antiepileptic drug gabapentin to enhance pharmaceutical properties with a multicomponent crystal strategy","volume":"22","author":"Zhao","year":"2022","journal-title":"Cryst Growth Des"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jct.2017.05.041","article-title":"Thermodynamic and molecular investigation into the solubility, stability and self-assembly of gabapentin anhydrate and hydrate","volume":"113","author":"Wang","year":"2017","journal-title":"J Chem Thermodyn"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"107017","DOI":"10.1016\/j.ejps.2025.107017","article-title":"Impact of disintegrants on rheological properties and printability in SSE 3D printing of immediate-release formulations","volume":"206","author":"Aina","year":"2025","journal-title":"Eur J Pharm Sci"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ijpharm.2010.06.014","article-title":"Solid-state transformation of different gabapentin polymorphs upon milling and co-milling","volume":"396","author":"Lin","year":"2010","journal-title":"Int J Pharm"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"239","DOI":"10.35814\/jifi.v21i2.1486","article-title":"Gelatin analysis in local soft candy products using Fourier transform infrared (ATR-FTIR) combined with chemometrics","volume":"21","author":"Salamah","year":"2023","journal-title":"Indones J Pharm Sci"}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2026.1835903\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:38:07Z","timestamp":1778647087000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2026.1835903\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":34,"alternative-id":["10.3389\/fvets.2026.1835903"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2026.1835903","relation":{},"ISSN":["2297-1769"],"issn-type":[{"value":"2297-1769","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"article-number":"1835903"}}